KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $928,000 | -1.3% | 5,163 | -43.0% | 0.11% | -16.3% |
| Q2 2017 | $940,000 | +1416.1% | 9,063 | +1051.6% | 0.14% | +1025.0% |
| Q1 2017 | $62,000 | -68.5% | 787 | -82.1% | 0.01% | -70.0% |
| Q4 2016 | $197,000 | -86.9% | 4,387 | -83.8% | 0.04% | -90.9% |
| Q3 2016 | $1,509,000 | +1455.7% | 27,018 | +1176.2% | 0.44% | +975.6% |
| Q1 2016 | $97,000 | +4750.0% | 2,117 | +5471.1% | 0.04% | +1950.0% |
| Q3 2015 | $2,000 | -98.4% | 38 | -98.2% | 0.00% | -98.7% |
| Q2 2015 | $126,000 | +44.8% | 2,072 | +38.1% | 0.15% | +2.8% |
| Q1 2015 | $87,000 | – | 1,500 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,358,084 | $105,736,000 | 48.63% |
| BAINCO INTERNATIONAL INVESTORS | 1,151,540 | $51,635,000 | 8.76% |
| Coastal Bridge Advisors, LLC | 250,040 | $11,212,000 | 4.36% |
| NEXTHERA CAPITAL LP | 150,000 | $6,726,000 | 3.94% |
| Casdin Capital, LLC | 94,000 | $4,215,000 | 3.48% |
| MENORA MIVTACHIM HOLDINGS LTD. | 1,258,899 | $56,449,000 | 2.90% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 85,000 | $3,812,000 | 2.14% |
| SECTORAL ASSET MANAGEMENT INC | 372,223 | $16,690,000 | 1.85% |
| ARK Investment Management | 97,313 | $4,364,000 | 1.59% |
| BB BIOTECH AG | 800,000 | $35,872,000 | 1.33% |